SCD4 Activators

Common SCD4 Activators include, but are not limited to Rosiglitazone CAS 122320-73-4, Insulin CAS 11061-68-0, T 0901317 CAS 293754-55-9, Oleic Acid CAS 112-80-1 and D(+)Glucose, Anhydrous CAS 50-99-7.

Stearoyl-CoA Desaturase 4, commonly known as SCD4, is an enzyme that is part of the SCD family responsible for the desaturation of fatty acids. The desaturation process primarily involves introducing a cis-double bond into saturated fatty acyl-CoAs, thereby transforming them into monounsaturated fatty acids. These monounsaturated fatty acids, chiefly oleic acid and palmitoleic acid, are instrumental in various aspects of lipid metabolism, including lipid signaling, membrane architecture, and overall maintenance of lipid homeostasis. The SCD family encompasses several isoforms, including SCD1, SCD2, SCD3, and SCD4. While each isoform exhibits its own unique tissue-specific expression patterns and distinct physiological roles, they all fundamentally share the core enzymatic activity centered around fatty acid desaturation.

CD4 Activators are a group of compounds or molecules designed to elevate or augment the enzymatic activity of SCD4. By doing so, these activators would propel the production of monounsaturated fatty acids by facilitating the conversion of saturated fatty acyl-CoAs. An enhanced activity of SCD4, driven by its activators, has implications in lipid biosynthesis, lipid droplet dynamics, and the regulation of lipid balance within cells. Additionally, given the integral role of monounsaturated fatty acids in several cellular mechanisms, SCD4 activators could indirectly influence a spectrum of cell signaling pathways, the dynamics of cellular membranes, and energy reservoirs within cells. The exploration of SCD4 activators provides an exciting opportunity to gain deeper insights into lipid metabolism's complexities and its overarching influence on cellular physiology and functionality.